Brief: Transcode Therapeutics Announces 1-For-28 Reverse Stock Split
02/05/2025 22:24
May 2 (Reuters) - Transcode Therapeutics Inc RNAZ.O: TRANSCODE THERAPEUTICS ANNOUNCES 1-FOR-28 REVERSE STOCK SPLIT TRANSCODE THERAPEUTICS INC - APPROVES 1-FOR-28 REVERSE STOCK SPLIT Source text: ID:nPnbdvGl7a Further company coverage: RNAZ.O (Reuters.Briefs@thomsonreuters.com)
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors